Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu
SAN ANTONIO (May 5, 2023) — Daniel Lodge, PhD, has been appointed chairman of the Department of Pharmacology at The University of Texas Health Science Center at San Antonio. The appointment, which took effect April 15, 2023, was announced by Robert Hromas, MD, dean of the health science center’s Joe R. and Teresa Lozano Long School of Medicine.
Lodge was born and raised in Melbourne, Australia. He completed his graduate studies in the Department of Pharmacology at Monash University in Australia. After graduation, he relocated to the United States to pursue postdoctoral training at the University of Pittsburgh, where he focused on the neuronal systems associated with psychosis.
In 2009, Lodge joined the faculty at UT Health San Antonio, where he has received continuous National Institutes of Health (NIH) funding to explore potential innovative treatments for disorders such as schizophrenia, post-traumatic stress disorder and Alzheimer’s disease.
Lodge’s research uses preclinical models to investigate the involvement of the hippocampus and thalamus in the regulation of dopamine neuron activity, both in normal and pathological conditions. Lodge has devised pharmacological, surgical and cell-based strategies that hold promise for treating psychosis.
In addition to his research, Lodge is deeply committed to mentorship, as demonstrated by his participation on the executive committee of the Mentoring Academy, his role as assistant director for the neuroscience discipline, and his leadership of the Neuroscience Student Oversight Committee. Since September 2022, he had served as the interim chairman of pharmacology. He has a compelling vision for advancing preclinical and translational research at UT Health Science Center San Antonio.
Among his other interests, Lodge is a race car enthusiast who enjoys driving cars on F1 tracks.
The University of Texas Health Science Center at San Antonio (UT Health San Antonio), a primary driver of San Antonio’s $44.1 billion health care and biosciences sector, is the largest academic research institution in South Texas, sustaining an annual research portfolio of more than $360 million. Driving substantial economic impact with its six professional schools, a diverse workforce of 7,900, an annual operating budget of $1.23 billion, clinical practices that provide 2.6 million patient visits each year, the largest medical practice in South Texas and more than 450 ongoing clinical trials, UT Health San Antonio plans to add 1,500 higher-wage jobs over the next five years to serve San Antonio, Bexar County and South Texas.
Additionally, over the next three years, the university will invest more than $1 billion reflecting unprecedented growth of its clinical mission, with the launch of the UT Health San Antonio Multispecialty and Research Hospital and UT Health at Kyle Seale Parkway; its education mission, with the addition of The University of Texas School of Public Health San Antonio; and its research mission, with the building of the UT Health San Antonio Center for Brain Health adjacent to its patient-care flagship, the Medical Arts and Research Center (MARC).
To learn more about the many ways “We make lives better®” through excellence in education, research, health care and community engagement, visit UTHealthSA.org.
Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.